199 related articles for article (PubMed ID: 17116302)
1. Cellular pharmacological properties of gold(III) porphyrin 1a, a potential anticancer drug lead.
Wang Y; He QY; Sun RW; Che CM; Chiu JF
Eur J Pharmacol; 2007 Jan; 554(2-3):113-22. PubMed ID: 17116302
[TBL] [Abstract][Full Text] [Related]
2. Proteomic characterization of the cytotoxic mechanism of gold (III) porphyrin 1a, a potential anticancer drug.
Wang Y; He QY; Che CM; Chiu JF
Proteomics; 2006 Jan; 6(1):131-42. PubMed ID: 16287165
[TBL] [Abstract][Full Text] [Related]
3. Stable anticancer gold(III)-porphyrin complexes: effects of porphyrin structure.
Sun RW; Li CK; Ma DL; Yan JJ; Lok CN; Leung CH; Zhu N; Che CM
Chemistry; 2010 Mar; 16(10):3097-113. PubMed ID: 20162647
[TBL] [Abstract][Full Text] [Related]
4. Gold (III) porphyrin complexes induce apoptosis and cell cycle arrest and inhibit tumor growth in colon cancer.
Tu S; Wai-Yin Sun R; Lin MC; Tao Cui J; Zou B; Gu Q; Kung HF; Che CM; Wong BC
Cancer; 2009 Oct; 115(19):4459-69. PubMed ID: 19572413
[TBL] [Abstract][Full Text] [Related]
5. Modulation of gold(III) porphyrin 1a-induced apoptosis by mitogen-activated protein kinase signaling pathways.
Wang Y; He QY; Che CM; Tsao SW; Sun RW; Chiu JF
Biochem Pharmacol; 2008 Mar; 75(6):1282-91. PubMed ID: 18241839
[TBL] [Abstract][Full Text] [Related]
6. GoldIII porphyrin 1a induced apoptosis by mitochondrial death pathways related to reactive oxygen species.
Wang Y; He QY; Sun RW; Che CM; Chiu JF
Cancer Res; 2005 Dec; 65(24):11553-64. PubMed ID: 16357165
[TBL] [Abstract][Full Text] [Related]
7. Overcoming cisplatin resistance using gold(III) mimics: anticancer activity of novel gold(III) polypyridyl complexes.
Palanichamy K; Sreejayan N; Ontko AC
J Inorg Biochem; 2012 Jan; 106(1):32-42. PubMed ID: 22112837
[TBL] [Abstract][Full Text] [Related]
8. Gold(III) compounds as anticancer agents: relevance of gold-protein interactions for their mechanism of action.
Casini A; Hartinger C; Gabbiani C; Mini E; Dyson PJ; Keppler BK; Messori L
J Inorg Biochem; 2008 Mar; 102(3):564-75. PubMed ID: 18177942
[TBL] [Abstract][Full Text] [Related]
9. A gold(III) porphyrin complex with antitumor properties targets the Wnt/beta-catenin pathway.
Chow KH; Sun RW; Lam JB; Li CK; Xu A; Ma DL; Abagyan R; Wang Y; Che CM
Cancer Res; 2010 Jan; 70(1):329-37. PubMed ID: 19996284
[TBL] [Abstract][Full Text] [Related]
10. The cisplatin-irradiation combination suggests that apoptosis is not a major determinant of clonogenic death.
Lo Nigro C; Arnolfo E; Taricco E; Fruttero A; Russi EG; Lucio F; Ribero S; Comino A; Merlano M; Ungari S
Anticancer Drugs; 2007 Jul; 18(6):659-67. PubMed ID: 17762394
[TBL] [Abstract][Full Text] [Related]
11. The cytotoxicity of high-linear energy transfer radiation is reinforced by oxaliplatin in human glioblastoma cells.
Benzina S; Debomy F; Bergerat JP; Denis JM; Gueulette J; Dufour P; Bischoff P
Cancer Lett; 2007 Aug; 254(1):54-62. PubMed ID: 17383816
[TBL] [Abstract][Full Text] [Related]
12. In vitro toxicity of palladium(II) and gold(III) porphyrins and their aqueous metal ion counterparts on Trypanosoma brucei brucei growth.
Nyarko E; Hara T; Grab DJ; Habib A; Kim Y; Nikolskaia O; Fukuma T; Tabata M
Chem Biol Interact; 2004 Jun; 148(1-2):19-25. PubMed ID: 15223353
[TBL] [Abstract][Full Text] [Related]
13. Anticancer and antimicrobial metallopharmaceutical agents based on palladium, gold, and silver N-heterocyclic carbene complexes.
Ray S; Mohan R; Singh JK; Samantaray MK; Shaikh MM; Panda D; Ghosh P
J Am Chem Soc; 2007 Dec; 129(48):15042-53. PubMed ID: 17988129
[TBL] [Abstract][Full Text] [Related]
14. Gold(III) compounds of 1,4,7-triazacyclononane showing high cytotoxicity against A-549 and HCT-116 tumor cell lines.
Shi P; Jiang Q; Lin J; Zhao Y; Lin L; Guo Z
J Inorg Biochem; 2006 May; 100(5-6):939-45. PubMed ID: 16472862
[TBL] [Abstract][Full Text] [Related]
15. A novel anticancer gold(III) dithiocarbamate compound inhibits the activity of a purified 20S proteasome and 26S proteasome in human breast cancer cell cultures and xenografts.
Milacic V; Chen D; Ronconi L; Landis-Piwowar KR; Fregona D; Dou QP
Cancer Res; 2006 Nov; 66(21):10478-86. PubMed ID: 17079469
[TBL] [Abstract][Full Text] [Related]
16. Antitumor properties of five-coordinate gold(III) complexes bearing substituted polypyridyl ligands.
Sanghvi CD; Olsen PM; Elix C; Peng SB; Wang D; Chen ZG; Shin DM; Hardcastle KI; MacBeth CE; Eichler JF
J Inorg Biochem; 2013 Nov; 128():68-76. PubMed ID: 23948576
[TBL] [Abstract][Full Text] [Related]
17. Gold compounds as anticancer agents: chemistry, cellular pharmacology, and preclinical studies.
Nobili S; Mini E; Landini I; Gabbiani C; Casini A; Messori L
Med Res Rev; 2010 May; 30(3):550-80. PubMed ID: 19634148
[TBL] [Abstract][Full Text] [Related]
18. In vitro biochemical and pharmacological evaluation of a novel cytotoxic dinuclear platinum(II) complex with 3-amino-5-methyl-5-phenylhydantoin.
Momekov GTs; Ugrinova I; Pasheva EA; Bakalova AG; Varbanov HP; Ferdinandov DV; Ivanov DS; Konstantinov SM
Ann N Y Acad Sci; 2009 Aug; 1171():649-58. PubMed ID: 19723116
[TBL] [Abstract][Full Text] [Related]
19. Gold(III) porphyrin 1a inhibited nasopharyngeal carcinoma metastasis in vivo and inhibited cell migration and invasion in vitro.
Lum CT; Liu X; Sun RW; Li XP; Peng Y; He ML; Kung HF; Che CM; Lin MC
Cancer Lett; 2010 Aug; 294(2):159-66. PubMed ID: 20163914
[TBL] [Abstract][Full Text] [Related]
20. Large-bite bis(phosphite) ligand containing mesocyclic thioether moieties: synthesis, reactivity, group 11 (Cu(I), Au(I)) metal complexes and anticancer activity studies on a human cervical cancer (HeLa) cell line.
Suresh D; Balakrishna MS; Rathinasamy K; Panda D; Mague JT
Dalton Trans; 2008 May; (17):2285-92. PubMed ID: 18414753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
